Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.
The targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal antibodies and sugar moieties serve as homing devices, ensuring precise localization of the drug at the intended site. This targeted approach enhances the therapeutic index of drugs, particularly in conditions requiring high specificity, such as cancer and gene therapy.
Polymeric carriers also include agents that improve drugs' physicochemical properties, thereby enhancing their transport and cellular uptake. The incorporation of solubilizers increases aqueous solubility, allowing for better dispersion and absorption of hydrophobic drugs. This modification is crucial in achieving effective bioavailability and prolonging systemic circulation time.
A cleavable spacer covalently links the drug to the polymeric backbone, allowing controlled release via hydrolysis or enzymatic cleavage. This ensures sustained drug availability, reducing dosing frequency and side effects.
Polymers such as polyethyleneimine, polylysine, chitosan, dextran, and PEG provide structural integrity, enhance stability, and ensure biocompatibility. They are commonly used for delivering proteins, peptides, and gene therapies. Micro- and nanoparticles optimize drug stability and controlled release. Smaller nanoparticles penetrate deeper into tissues, improving drug distribution and cellular uptake, which is crucial for cancer therapy.
Recent advancements in polymeric drug delivery improve treatments in cancer therapy, gene therapy, and controlled-release formulations. These innovations continue to enhance precision medicine and targeted therapeutic approaches.
Polymeric carriers enhance site-targeted drug delivery, increasing efficacy while minimizing off-target effects.
They consist of a biodegradable polymeric backbone, a homing device for targeting, functional chains that enhance physicochemical properties, and a cleavable spacer for controlled drug release.
Common polymers include polyethyleneimine, polylysine, chitosan, dextran, and PEG. These are employed to deliver proteins and peptides and in gene therapies.
The homing device is a molecular recognition component, such as monoclonal antibodies or sugar moieties, that enables selective binding to target tissues.
Adding solubilizers improves physicochemical properties, such as aqueous solubility, enhancing drug transport and cellular uptake.
A spacer covalently links the drug to the carrier, facilitating controlled release through various mechanisms.
Micro- and nanoparticles improve drug stability and controlled release; smaller nanoparticles penetrate deeper into tissues.
Advances in polymeric drug delivery improve cancer and gene therapy treatments and controlled-release formulations.
繁體中文
